Metropolis Healthcare Limited (METROPOLIS) - Net Assets

Latest as of September 2025: Rs14.43 Billion INR ≈ $156.07 Million USD

Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has net assets worth Rs14.43 Billion INR (≈ $156.07 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs19.93 Billion ≈ $215.49 Million USD) and total liabilities (Rs5.49 Billion ≈ $59.42 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check METROPOLIS financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs14.43 Billion
% of Total Assets	72.43%
Annual Growth Rate	13.93%
5-Year Change	88.49%
10-Year Change	354.14%
Growth Volatility	15.33

Metropolis Healthcare Limited - Net Assets Trend (2014–2025)

This chart illustrates how Metropolis Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Also explore Metropolis Healthcare Limited total assets for the complete picture of this company's asset base.

Annual Net Assets for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual net assets of Metropolis Healthcare Limited from 2014 to 2025. For live valuation and market cap data, see Metropolis Healthcare Limited market capitalisation.

Year	Net Assets	Change
2025-03-31	Rs13.35 Billion ≈ $144.34 Million	+21.41%
2024-03-31	Rs10.99 Billion ≈ $118.88 Million	+10.96%
2023-03-31	Rs9.91 Billion ≈ $107.14 Million	+11.55%
2022-03-31	Rs8.88 Billion ≈ $96.05 Million	+25.44%
2021-03-31	Rs7.08 Billion ≈ $76.57 Million	+34.83%
2020-03-31	Rs5.25 Billion ≈ $56.79 Million	+25.05%
2019-03-31	Rs4.20 Billion ≈ $45.42 Million	-2.14%
2018-03-31	Rs4.29 Billion ≈ $46.41 Million	+24.69%
2017-03-31	Rs3.44 Billion ≈ $37.22 Million	+17.11%
2016-03-31	Rs2.94 Billion ≈ $31.78 Million	-23.53%
2015-03-31	Rs3.84 Billion ≈ $41.56 Million	+20.93%
2014-03-31	Rs3.18 Billion ≈ $34.37 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Metropolis Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 341.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs10.31 Billion	77.49%
Common Stock	Rs103.60 Million	0.78%
Other Comprehensive Income	Rs430.47 Million	3.23%
Other Components	Rs2.46 Billion	18.50%
Total Equity	Rs13.31 Billion	100.00%

Metropolis Healthcare Limited Competitors by Market Cap

The table below lists competitors of Metropolis Healthcare Limited ranked by their market capitalization.

Company	Market Cap
Qinghaihuading Industrial Co Ltd SHG:600243	$267.15 Million
Topco Technologies TWO:3388	$267.17 Million
Kina Securities Ltd AU:KSL	$267.41 Million
Kleannara Co Ltd KO:004545	$267.51 Million
ANTENGENE CORP. DL-0001 F:722	$267.00 Million
Kiri Industries Limited NSE:KIRIINDUS	$266.95 Million
Eaton Vance National Municipal Opportunities Closed Fund NYSE:EOT	$266.87 Million
Blue Water Acquisition Corp. III Class A Ordinary Shares NASDAQ:BLUW	$266.85 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Metropolis Healthcare Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 10,961,555,000 to 13,309,720,000, a change of 2,348,165,000 (21.4%).
Net income of 1,449,683,000 contributed positively to equity growth.
Share repurchases of 102,000 reduced equity.
New share issuances of 102,000 increased equity.
Other comprehensive income increased equity by 17,404,000.
Other factors increased equity by 881,078,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs1.45 Billion	+10.89%
Share Repurchases	Rs102.00K	-0.0%
Share Issuances	Rs102.00K	+0.0%
Other Comprehensive Income	Rs17.40 Million	+0.13%
Other Changes	Rs881.08 Million	+6.62%
Total Change	Rs-	21.42%

Book Value vs Market Value Analysis

This analysis compares Metropolis Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.84x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 8.09x to 1.84x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-03-31	Rs58.94	Rs476.50	x
2015-03-31	Rs70.54	Rs476.50	x
2016-03-31	Rs54.95	Rs476.50	x
2017-03-31	Rs64.69	Rs476.50	x
2018-03-31	Rs83.10	Rs476.50	x
2019-03-31	Rs83.66	Rs476.50	x
2020-03-31	Rs103.80	Rs476.50	x
2021-03-31	Rs138.11	Rs476.50	x
2022-03-31	Rs172.36	Rs476.50	x
2023-03-31	Rs192.38	Rs476.50	x
2024-03-31	Rs213.28	Rs476.50	x
2025-03-31	Rs258.48	Rs476.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Metropolis Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.89%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 10.89%
• Asset Turnover: 0.71x
• Equity Multiplier: 1.40x
Recent ROE (10.89%) is below the historical average (21.65%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	18.71%	14.57%	0.99x	1.30x	Rs263.28 Million
2015	16.85%	13.39%	0.98x	1.28x	Rs247.91 Million
2016	27.55%	16.15%	1.20x	1.42x	Rs489.24 Million
2017	31.46%	18.66%	1.06x	1.59x	Rs693.40 Million
2018	25.13%	16.11%	1.22x	1.28x	Rs627.59 Million
2019	28.71%	15.78%	1.38x	1.32x	Rs782.94 Million
2020	24.32%	14.87%	1.14x	1.44x	Rs749.76 Million
2021	25.91%	18.35%	0.99x	1.42x	Rs1.12 Billion
2022	24.17%	17.44%	0.80x	1.73x	Rs1.26 Billion
2023	14.46%	12.44%	0.76x	1.52x	Rs440.59 Million
2024	11.66%	10.58%	0.78x	1.42x	Rs182.01 Million
2025	10.89%	10.89%	0.71x	1.40x	Rs118.71 Million

Industry Comparison

This section compares Metropolis Healthcare Limited's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $2,918,873,338
Average return on equity (ROE) among peers: 13.32%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Metropolis Healthcare Limited (METROPOLIS)	Rs14.43 Billion	18.71%	0.38x	$267.10 Million
Krsnaa Diagnostics Limited (KRSNAA)	$-228.96 Million	0.00%	0.00x	$206.54 Million
Dr. Lal Path Labs Ltd. (LALPATHLAB)	$5.10 Billion	25.94%	0.23x	$2.47 Billion
Syngene International Limited (SYNGENE)	$2.21 Billion	12.32%	1.28x	$2.03 Billion
Thyrocare Technologies Limited (THYROCARE)	$3.67 Billion	24.11%	0.28x	$689.03 Million
Vijaya Diagnostic Centre Limited (VIJAYA)	$5.47 Billion	15.48%	0.56x	$1.26 Billion
Vimta Labs Limited (VIMTALABS)	$1.31 Billion	2.03%	0.39x	$220.67 Million

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research

Market Cap

$267.10 Million

Rs24.70 Billion INR

Market Cap Rank

#15437 Global

#763 in India

Share Price

Rs476.50

Change (1 day)

-0.48%

52-Week Range

Rs421.75 - Rs2236.70

All Time High

Rs3431.71